148 related articles for article (PubMed ID: 9509801)
1. Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials.
Coyle D; Davies L; Drummond MF
Int J Technol Assess Health Care; 1998; 14(1):135-44. PubMed ID: 9509801
[TBL] [Abstract][Full Text] [Related]
2. Economic analysis alongside clinical trials. Revisiting the methodological issues.
Drummond MF; Davies L
Int J Technol Assess Health Care; 1991; 7(4):561-73. PubMed ID: 1778701
[TBL] [Abstract][Full Text] [Related]
3. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations?
O'Sullivan AK; Thompson D; Drummond MF
Value Health; 2005; 8(1):67-79. PubMed ID: 15841896
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
[TBL] [Abstract][Full Text] [Related]
5. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
Doshi JA; Glick HA; Polsky D
Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
[TBL] [Abstract][Full Text] [Related]
6. Health services research clinical trials: issues in the evaluation of economic costs and benefits.
Manheim LM
Control Clin Trials; 1998 Apr; 19(2):149-58. PubMed ID: 9551279
[TBL] [Abstract][Full Text] [Related]
7. Assessing the costs of healthcare technologies in clinical trials.
Johnston K; Buxton MJ; Jones DR; Fitzpatrick R
Health Technol Assess; 1999; 3(6):1-76. PubMed ID: 10350450
[No Abstract] [Full Text] [Related]
8. Analyzing differences in the costs of treatment across centers within economic evaluations.
Coyle D; Drummond MF
Int J Technol Assess Health Care; 2001; 17(2):155-63. PubMed ID: 11446127
[TBL] [Abstract][Full Text] [Related]
9. Analysis and interpretation of cost data in randomised controlled trials: review of published studies.
Barber JA; Thompson SG
BMJ; 1998 Oct; 317(7167):1195-200. PubMed ID: 9794854
[TBL] [Abstract][Full Text] [Related]
10. Factors to consider when designing phase III clinical trials involving economic evaluations.
van Enckevort PJ; TenVergert EM; Kingma J; Koëter GH; Rutten FF
Percept Mot Skills; 1999 Dec; 89(3 Pt 2):1059-72. PubMed ID: 10710753
[TBL] [Abstract][Full Text] [Related]
11. Improving the validity of economic evaluations alongside controlled trials.
Dixon S; Deverill M; Gannon M; Brazier J; Haggard M
J Health Serv Res Policy; 1999 Jul; 4(3):161-3. PubMed ID: 10538881
[No Abstract] [Full Text] [Related]
12. Economic evaluations and randomized trials in spinal disorders: principles and methods.
Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
[TBL] [Abstract][Full Text] [Related]
13. Analysis of costs and cost-effectiveness in multinational trials.
Koopmanschap MA; Touw KC; Rutten FF
Health Policy; 2001 Nov; 58(2):175-86. PubMed ID: 11551665
[TBL] [Abstract][Full Text] [Related]
14. Measuring costs in multisite randomized controlled trials: lessons from the VA Cooperative Studies Program.
Hynes D; Reda D; Giobbie-Hurder A; Abdellatif M; Weinberger M; Oddone E; Wasson J; Henderson W
Med Care; 1999 Apr; 37(4 Suppl Va):AS27-36. PubMed ID: 10217382
[TBL] [Abstract][Full Text] [Related]
15. Analytic considerations in economic evaluations of multinational cardiovascular clinical trials.
Torti FM; Reed SD; Schulman KA
Value Health; 2006; 9(5):281-91. PubMed ID: 16961546
[TBL] [Abstract][Full Text] [Related]
16. Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches.
Hughes D; Charles J; Dawoud D; Edwards RT; Holmes E; Jones C; Parham P; Plumpton C; Ridyard C; Lloyd-Williams H; Wood E; Yeo ST
Pharmacoeconomics; 2016 May; 34(5):447-61. PubMed ID: 26753558
[TBL] [Abstract][Full Text] [Related]
17. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
O'Hagan A; Stevens JW
Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial and economic evaluation.
Jain S; Arora NK
Indian J Pediatr; 2000 May; 67(5):363-8. PubMed ID: 10885210
[TBL] [Abstract][Full Text] [Related]
19. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
Graves N; Walker D; Raine R; Hutchings A; Roberts JA
Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based medicine and health economics: a case study of end stage renal disease.
Vale L; Donaldson C; Daly C; Campbell M; Cody J; Grant A; Khan I; Lawrence P; Wallace S; MacLeod A
Health Econ; 2000 Jun; 9(4):337-51. PubMed ID: 10862077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
